IHM
SLXP

Iguana Healthcare Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Iguana Healthcare Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-15,000
Closed -$2.34M – 79
2014
Q3 		$2.34M Sell
15,000
-12,500
-45% -$1.81M 1.25% 34
2014
Q2 		$3.39M Buy
+27,500
New +$3.04M 1.58% 26

Other funds holding SLXP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Investors US
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Iguana Healthcare Management's SLXP Position: Q4 2014 in Review

Iguana Healthcare Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 15,000 shares — an estimated $2.34M sold.

Iguana Healthcare Management first reported a position in SLXP in Q2 2014 and held it in 2 quarters. The position peaked at $3.39M in Q2 2014. 347 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • Iguana Healthcare Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
  • Iguana Healthcare Management sold 15,000 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $2.34M.
  • Iguana Healthcare Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 2 quarters.
  • Iguana Healthcare Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.39M in Q2 2014.
  • 347 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on Iguana Healthcare Management's 13F filing for Q4 2014, filed 18 Feb 2015.